SG11201605336YA - Composition and method for the protection of articular cartilage - Google Patents
Composition and method for the protection of articular cartilageInfo
- Publication number
- SG11201605336YA SG11201605336YA SG11201605336YA SG11201605336YA SG11201605336YA SG 11201605336Y A SG11201605336Y A SG 11201605336YA SG 11201605336Y A SG11201605336Y A SG 11201605336YA SG 11201605336Y A SG11201605336Y A SG 11201605336YA SG 11201605336Y A SG11201605336Y A SG 11201605336YA
- Authority
- SG
- Singapore
- Prior art keywords
- protection
- composition
- articular cartilage
- articular
- cartilage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2014/010993 WO2015105501A1 (en) | 2014-01-10 | 2014-01-10 | Composition and method for the protection of articular cartilage |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201605336YA true SG11201605336YA (en) | 2016-07-28 |
Family
ID=53524213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201605336YA SG11201605336YA (en) | 2014-01-10 | 2014-01-10 | Composition and method for the protection of articular cartilage |
Country Status (9)
Country | Link |
---|---|
JP (1) | JP6142446B2 (en) |
KR (2) | KR101685333B1 (en) |
AU (1) | AU2014201769B2 (en) |
CA (1) | CA2935898C (en) |
EA (1) | EA027614B1 (en) |
NZ (1) | NZ622909A (en) |
PH (1) | PH12016501138B1 (en) |
SG (1) | SG11201605336YA (en) |
WO (1) | WO2015105501A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6887898B1 (en) | 1999-10-22 | 2005-05-03 | Darrick S. H. L. Kim | Pharmaceutical compositions useful in prevention and treatment of beta-Amyloid protein-induced disease |
GB2439960B (en) | 2006-07-08 | 2011-11-16 | Redweb Security | Material for marking an article using DNA |
CN101516364B (en) * | 2006-07-14 | 2011-12-28 | 帝斯曼知识产权资产管理有限公司 | Compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
US8577013B1 (en) | 2011-01-10 | 2013-11-05 | West Corporation | Automatic communications forwarding to displaced employees |
-
2014
- 2014-01-10 KR KR1020167014135A patent/KR101685333B1/en active IP Right Grant
- 2014-01-10 JP JP2016516634A patent/JP6142446B2/en not_active Expired - Fee Related
- 2014-01-10 CA CA2935898A patent/CA2935898C/en active Active
- 2014-01-10 WO PCT/US2014/010993 patent/WO2015105501A1/en active Application Filing
- 2014-01-10 AU AU2014201769A patent/AU2014201769B2/en not_active Ceased
- 2014-01-10 NZ NZ622909A patent/NZ622909A/en not_active IP Right Cessation
- 2014-01-10 KR KR1020147009279A patent/KR101685263B1/en active IP Right Grant
- 2014-01-10 SG SG11201605336YA patent/SG11201605336YA/en unknown
- 2014-01-10 EA EA201591212A patent/EA027614B1/en unknown
-
2016
- 2016-06-13 PH PH12016501138A patent/PH12016501138B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2935898C (en) | 2018-11-06 |
PH12016501138A1 (en) | 2016-07-18 |
EA201591212A1 (en) | 2015-10-30 |
AU2014201769B2 (en) | 2018-05-24 |
PH12016501138B1 (en) | 2016-07-18 |
WO2015105501A1 (en) | 2015-07-16 |
JP2016520126A (en) | 2016-07-11 |
KR20160087387A (en) | 2016-07-21 |
JP6142446B2 (en) | 2017-06-07 |
KR101685263B1 (en) | 2016-12-09 |
KR101685333B1 (en) | 2016-12-09 |
KR20150105185A (en) | 2015-09-16 |
EA201591212A8 (en) | 2016-05-31 |
CA2935898A1 (en) | 2015-07-16 |
AU2014201769A1 (en) | 2015-07-30 |
NZ622909A (en) | 2018-04-27 |
EA027614B1 (en) | 2017-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL285565B (en) | Methods and compositions for immunomodulation | |
HK1257295A1 (en) | Compositions and methods for immunooncology | |
ZA201705908B (en) | Compositions and methods for the reduction or prevention of hepatic steatosis | |
GB2535253B (en) | Compositions and methods | |
HUE056172T2 (en) | Compositions of selenoorganic compounds and methods of use thereof | |
EP3201187A4 (en) | Compositions and methods for inhibiting bmp | |
GB201417828D0 (en) | New methods and compositions | |
IL246879B (en) | Apilimod compositions and methods for using same | |
HK1245158A1 (en) | Apilimod compositions and methods for using same | |
EP3122355A4 (en) | Compositions and methods for inhibiting bmp | |
IL249226A0 (en) | Methods and compositions for immunomodulation | |
HK1246193A1 (en) | Methods and compositions for improved cognition | |
HK1252057A1 (en) | Novel method of use and compositions | |
ZA201605109B (en) | Compositions and methods for treating neutropenia | |
GB201520255D0 (en) | Composition and method | |
GB201705822D0 (en) | Proppant composition and method | |
IL266361A (en) | Methods and compositions for treatment of cartilage damage and arthritis | |
IL248420A0 (en) | Compositions and methods useful for removing tablet coatings | |
PL3113774T3 (en) | Compositions of grapiprant and methods for using the same | |
IL251238A0 (en) | Mineral based compositions and use thereof | |
IL248513B (en) | Compositions and methods for anti-lyst immunomodulation | |
GB201509420D0 (en) | Composition and method | |
HK1210028A1 (en) | Composition and method for the protection of articular cartilage | |
GB201513492D0 (en) | Method and composition | |
SG11201605336YA (en) | Composition and method for the protection of articular cartilage |